Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram
6 Diazo 5 Oxonorleucine - an overview | ScienceDirect Topics
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of Medicinal Chemistry
6-diazo-5-oxo-L-nor-Leucine (DON, NSC 7365, CAS Number: 157-03-9) | Cayman Chemical
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer | Scientific Reports
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes | PLOS Biology
6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E
6-diazo-5-oxo-L-norleucine | C6H9N3O3 - PubChem
6-Diazo-5-oxo-L-norleucine - Wikipedia
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells
a U251 were treated with l-asparaginase and/or... | Download Scientific Diagram
6-Diazo-5-oxo-L-norleucine - LabNet Biotecnica
6-Diazo-5-oxo-L-norleucine (CAS 157-03-9) | Glentham Life Sciences
Chemical reactivity of 6-diazo-5-oxo-l-norleucine (DON) catalyzed by metalloporphyrins (Fe,Ru) - ScienceDirect
FD49029 | 157-03-9 | 6-Diazo-5-oxo-L-norleucine
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents